News headlines about UnitedHealth Group (NYSE:UNH) have trended neutral recently, InfoTrie reports. The research group identifies negative and positive news coverage by analyzing more than 6,000 news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. UnitedHealth Group earned a daily sentiment score of 0.40 on their scale. InfoTrie also gave news coverage about the healthcare conglomerate an news buzz score of 4 out of 10, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.
These are some of the media stories that may have impacted UnitedHealth Group’s analysis:
Shares of NYSE UNH traded down $4.81 during mid-day trading on Monday, reaching $243.82. 1,928,924 shares of the company were exchanged, compared to its average volume of 3,650,393. UnitedHealth Group has a 52 week low of $208.07 and a 52 week high of $287.94. The company has a quick ratio of 0.73, a current ratio of 0.67 and a debt-to-equity ratio of 0.62. The stock has a market cap of $234.66 billion, a PE ratio of 18.93, a PEG ratio of 1.32 and a beta of 0.61. The stock has a 50 day moving average of $251.66.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, July 18th. The healthcare conglomerate reported $3.60 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.46 by $0.14. UnitedHealth Group had a net margin of 5.51% and a return on equity of 25.20%. The company had revenue of $60.60 billion during the quarter, compared to the consensus estimate of $60.59 billion. During the same period in the previous year, the firm posted $3.14 EPS. The firm’s revenue was up 8.0% compared to the same quarter last year. Equities analysts anticipate that UnitedHealth Group will post 14.82 EPS for the current year.
Several equities research analysts have recently issued reports on the stock. Zacks Investment Research upgraded shares of UnitedHealth Group from a “sell” rating to a “buy” rating and set a $269.00 price target for the company in a research note on Monday, July 22nd. Cleveland Research reiterated a “buy” rating on shares of UnitedHealth Group in a research note on Monday, July 15th. Royal Bank of Canada set a $311.00 price target on shares of UnitedHealth Group and gave the company a “buy” rating in a research report on Friday, July 19th. Raymond James boosted their price target on shares of UnitedHealth Group from $265.00 to $300.00 and gave the company a “buy” rating in a research report on Friday, July 19th. Finally, UBS Group assumed coverage on shares of UnitedHealth Group in a research report on Tuesday, April 23rd. They set a “neutral” rating and a $238.00 price target for the company. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and eighteen have issued a buy rating to the company’s stock. UnitedHealth Group currently has an average rating of “Buy” and an average price target of $295.06.
In other UnitedHealth Group news, Director Richard T. Burke sold 10,000 shares of the business’s stock in a transaction on Tuesday, June 11th. The shares were sold at an average price of $248.00, for a total value of $2,480,000.00. Following the completion of the sale, the director now directly owns 187,663 shares of the company’s stock, valued at $46,540,424. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director William C. Ballard, Jr. sold 12,000 shares of the business’s stock in a transaction on Tuesday, July 23rd. The stock was sold at an average price of $255.31, for a total transaction of $3,063,720.00. Following the completion of the sale, the director now directly owns 61,309 shares of the company’s stock, valued at $15,652,800.79. The disclosure for this sale can be found here. Insiders have sold a total of 37,000 shares of company stock valued at $9,195,620 over the last ninety days. 0.87% of the stock is currently owned by insiders.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children’s Health Insurance Program, and health care programs; and health and dental benefits.
Featured Article: What is a Special Dividend?
Receive News & Ratings for UnitedHealth Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group and related companies with MarketBeat.com’s FREE daily email newsletter.